153 related articles for article (PubMed ID: 18299551)
1. Finasteride therapy for benign prostatic hyperplasia.
Helling TJ
CMAJ; 2008 Feb; 178(5):596-7. PubMed ID: 18299551
[No Abstract] [Full Text] [Related]
2. Dutasteride and prostate cancer.
Garattini S; Bertele' V
N Engl J Med; 2010 Aug; 363(8):794; author reply 794-6. PubMed ID: 20842790
[No Abstract] [Full Text] [Related]
3. Finasteride: middle-age cure-all for alopecia and benign prostatic hyperplasia?
Federman DG
Mayo Clin Proc; 2006 Feb; 81(2):267; author reply 267-8. PubMed ID: 16471089
[No Abstract] [Full Text] [Related]
4. The effect of finasteride in men with benign prostatic hyperplasia. 1992.
Gormley GJ; Stoner E; Bruskewitz RC; Imperato-McGinley J; Walsh PC; McConnell JD; Andriole GL; Geller J; Bracken BR; Tenover JS; Vaughan ED; Pappas F; Taylor A; Binkowitz B; Ng J;
J Urol; 2002 Feb; 167(2 Pt 2):1102-7; discussion 1108. PubMed ID: 11905882
[No Abstract] [Full Text] [Related]
5. Preventing prostate cancer. Finasteride shrinks enlarged prostates and may prevent some cases of prostate cancer. But it's no panacea.
Beer TM
Health News; 2003 Aug; 9(8):1-2. PubMed ID: 12971313
[No Abstract] [Full Text] [Related]
6. Evaluation of men on finasteride.
Gormley GJ
Semin Urol Oncol; 1996 Aug; 14(3):139-44. PubMed ID: 8865475
[TBL] [Abstract][Full Text] [Related]
7. [Hormonal therapy for benign prostatic hyperplasia].
Sakai H; Kanetake H
Nihon Rinsho; 2002 Dec; 60 Suppl 11():358-61. PubMed ID: 12599600
[No Abstract] [Full Text] [Related]
8. Advances in the medical management of benign prostatic hyperplasia.
Jewett MA; Klotz LH;
CMAJ; 2007 Jun; 176(13):1850-1. PubMed ID: 17576985
[No Abstract] [Full Text] [Related]
9. Editorial comment.
Montie JE
Urology; 2009 May; 73(5):939; author reply 939. PubMed ID: 19394485
[No Abstract] [Full Text] [Related]
10. [Dual 5-alpha reductase inhibitors in BPH (benign prostatic hyperplasia). Already after 1 month prostate shrinks].
MMW Fortschr Med; 2003 Feb; 145(9):54. PubMed ID: 12666533
[No Abstract] [Full Text] [Related]
11. Finasteride and doxazosin alone or in combination for the treatment of benign prostatic hyperplasia.
Bhardwa J; Goldstraw M; Tzortzis S; Kirby R
Expert Opin Pharmacother; 2007 Jun; 8(9):1337-44. PubMed ID: 17563267
[TBL] [Abstract][Full Text] [Related]
12. Medical treatment of benign prostatic hyperplasia.
Connolly SS; Fitzpatrick JM
Postgrad Med J; 2007 Feb; 83(976):73-8. PubMed ID: 17308208
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of benign prostatic hyperplasia with finasteride and doxazosin -- long-term studies support the combination].
Hausmann R; Thalmann G; Reich O; Steif CG
Aktuelle Urol; 2004 Sep; 35(5):339-42. PubMed ID: 15383991
[No Abstract] [Full Text] [Related]
14. [Significance of 5-alpha-reductase inhibitors in therapy of benign prostatic hyperplasia with mild to modern symptoms].
Wirth MP; Helke C; Froschermaier SE
Urologe A; 1997 Jan; 36(1):35-9. PubMed ID: 9123679
[TBL] [Abstract][Full Text] [Related]
15. Finasteride-related cutaneous vaculitis.
Lear JT; Byrne JP
Postgrad Med J; 1996 Feb; 72(844):127. PubMed ID: 8871471
[No Abstract] [Full Text] [Related]
16. Mixed reviews for drug studied to prevent prostate cancer.
Mayo Clin Health Lett; 2003 Oct; 21(10):4. PubMed ID: 14619781
[No Abstract] [Full Text] [Related]
17. Finasteride to prevent morbidity from benign prostatic hyperplasia.
Wasson JH
N Engl J Med; 1998 Feb; 338(9):612-3. PubMed ID: 9475770
[No Abstract] [Full Text] [Related]
18. [Finasteride in prolonged therapy of patients with benign prostatic hyperplasia].
Mazo EB
Urologiia; 2001; (3):20-2. PubMed ID: 11505535
[TBL] [Abstract][Full Text] [Related]
19. Prevention of prostate cancer with finasteride.
Schwartz DT
N Engl J Med; 2003 Oct; 349(16):1569-72; author reply 1569-72. PubMed ID: 14562808
[No Abstract] [Full Text] [Related]
20. Finasteride in benign prostatic hyperplasia.
Wysowski DK; Farinas E
N Engl J Med; 2004 Mar; 350(13):1359-61; author reply 1359-61. PubMed ID: 15044649
[No Abstract] [Full Text] [Related]
[Next] [New Search]
